Questionnaire study in Japanese patients with generalized anxiety disorder (GAD)

Questionnaire study in Japanese patients with generalized anxiety disorder (GAD) - Questionnaire study in Japanese patients with generalized anxiety disorder (GAD)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057689

Enrollment

219

Registered

2025-04-23

Start date

2025-04-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized anxiety disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with GAD (diagnosed according to DSM-5) who participated in "A placebo-controlled, randomized, double-blind, multicenter study to evaluate the efficacy and safety of venlafaxine in Japanese outpatients with generalized anxiety disorder (Study B2411367)" via a clinical trial information website and meet the following criteria will be included in analyses. 1.Voluntarily consented to participate in this study by electronic means

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Endpoint 1: Awareness of GAD and medical care-seeking behavior until diagnosis Endpoint 2: Symptoms of GAD at trial entry Endpoint 3: Visits to the clinical trial site and diagnosis Endpoint 4: Situation from after the end of the clinical trial to the present Endpoint 5: Efforts needed to promote disease awareness	—

Countries

Japan

Contacts

Public ContactAyaka Sato

3H Medi Solution Inc. Patient Recruitment Group

info@c-trial.com03-5953-2108

Outcome results